Device / Technology News

RSS

Researchers develop method to generate billions of cDC1 immune cells

Conventional type 1 dendritic cells, known as cDC1 cells, are immune cells that help initiate responses against intracellular pathogens and tumors.

4 Nov 2026

AI-enabled Mayo Clinic tool supports individualized patient care decisions

Mayo Clinic Platform announced today the launch of a new Clinical Decision Support (CDS) solution that brings Mayo Clinic knowledge and evidence-informed guidance directly into clinicians' workflows, helping them access trusted, relevant information when and where they are making patient care decisions

4 Nov 2026

AlphaFold3 reveals molecular interactions driving T cell recognition

Researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, have developed a new approach using the artificial intelligence platform AlphaFold3 to predict whether a T cell receptor will recognize a specific antigen based solely on its genetic sequence.

3 Nov 2026

Study reveals widespread abuse involving non-consensual AI-generated intimate images

Around one in 15 adults has experienced AI-generated image-based abuse, according to a new study.

3 Nov 2026

ACLM and eClinicalWorks announce the release of new lifestyle medicine tools

The American College of Lifestyle Medicine (ACLM) and eClinicalWorks today announced that new lifestyle medicine tools will be available within the eClinicalWorks electronic health record (EHR) 12.0.4, helping clinicians more seamlessly incorporate evidence-based lifestyle interventions into routine patient care.

3 Nov 2026

Advanced imaging tool improves detection of residual multiple myeloma disease

A targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, a finding that could help doctors more accurately map disease, guide treatment decisions and confirm whether cancer remains after therapy.

3 Nov 2026

Innovative AI system could prevent testing delays in clinical laboratories

Weill Cornell Medicine researchers have designed an AI system that could help clinical laboratories identify problems before they disrupt testing and delay patient care.

3 Nov 2026

First Medicare ExRad study reveals wide variation in CT radiation

The first study to examine how imaging facilities perform on the new Medicare "ExRad" measure shows that radiation doses used for the same type of CT scan vary widely from one facility to the next.

3 Nov 2026

Nanoparticle structural design improves disease biomarker detection sensitivity

A nanoparticle's performance depends on more than what it is made of-it can also depend on how its building blocks are arranged.

3 Nov 2026

Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial begins

Auditory hallucinations – or hearing voices that others do not hear – affect more than 70% of people with schizophrenia. Despite treatment with antipsychotic medications, approximately 40% continue to experience persistent hallucinations. For these patients, new treatment approaches are urgently needed.

3 Nov 2026

AI-powered heart MRI measurements better predict patients' survival

Artificial intelligence (AI) measurements of heart function from MRI scans are more strongly linked to how long patients live after their scan than measurements made by clinicians, suggesting that AI could provide a useful first-line approach to measuring heart function.

2 Nov 2026

AI improves accuracy and completeness of hospital discharge summaries

The use of artificial intelligence (AI) could help physicians prepare hospital patient discharge summaries more efficiently, and with greater accuracy and completeness.

2 Nov 2026

Wearable devices and AI provide early warning signs of hypertensive crises

Using artificial intelligence (AI) to analyze patterns in measures from a portable cuff-based blood pressure monitor and health data from a wrist-worn device may help identify when adults with stage 2 high blood pressure (blood pressure ≥140/90 mm Hg) are at increased risk of a dangerously high blood pressure episode (>180/120 mm Hg with acute end-organ damage), known as a hypertensive crisis, up to three days before it occurs, according to new, independent, preliminary research to be presented at the American Heart Association's Scientific Sessions 2026.

2 Nov 2026

New study evaluates quantum machine learning for lung cancer prediction

Developing reliable machine learning models for healthcare can be challenging when only small datasets are available. This challenge motivates research into whether quantum computing approaches can learn useful patterns from limited symptom and risk-factor data.

2 Nov 2026

Mount Sinai receives NIH grant to study advanced MRI methods for locating seizures

Researchers at the Icahn School of Medicine at Mount Sinai have received more than $3 million from the National Institutes of Health (NIH) for a five-year study of advanced magnetic resonance imaging (MRI) methods that may help locate seizure-causing brain regions in people with drug-resistant epilepsy.

2 Nov 2026

New computational tool simulates evolution of jumping genes

A genome contains all of the DNA of every living organism, but its contents don't stop there – most of these structures also contain snippets of DNA that can copy and paste themselves to "infect" a genome, expanding its size.

2 Nov 2026

African nations seek decision-making power over gene-drive malaria tools

Gene-drive technology, which could stop mosquitoes spreading malaria, is so far confined to laboratories. But as researchers work towards possible field trials in Africa, questions emerge about who will decide how the technology is tested, governed and used.

2 Nov 2026

From simple ovulation treatments to IVF, how doctors choose the right approach

A clinical review on female infertility discusses causes, IVF options, and complications, equipping clinicians to improve patient care and treatment outcomes.

2 Nov 2026

Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trials

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced the publication of a peer-reviewed Viewpoint in the European Respiratory Journal (ERJ).

From Qureight 2 Nov 2026